InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Kaye Randall. Director active across 1 company, notably Longboard Pharmaceuticals, Inc.. In total, 6 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €2k. History available since 8 February 2024. The latest transaction was filed on 2 December 2024 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Kaye Randall is a declarant linked to Longboard Pharmaceuticals, Inc. She has 6 filings in total, and in the recent filings observed, the buy amount is EUR 2281 with no sales, over the period from 2024-02-09 to 2024-12-02. The most frequent transaction nature is option exercise.